{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:33:52Z","timestamp":1778528032277,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bioactmat.2024.05.028","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T12:04:20Z","timestamp":1716465860000},"page":"255-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Intra-articular sustained-release of pirfenidone as a disease-modifying treatment for early osteoarthritis"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-990X","authenticated-orcid":false,"given":"Xiaobo","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingde","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2108-3277","authenticated-orcid":false,"given":"Yau-Tsz","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0573-1251","authenticated-orcid":false,"given":"Hon-Fai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3528-1677","authenticated-orcid":false,"given":"Yi-Wah","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4400-7725","authenticated-orcid":false,"given":"Hao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Tim-Yun","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-8475","authenticated-orcid":false,"given":"Kevin Ki-Wai","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6679-0020","authenticated-orcid":false,"given":"Chien-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5232-5374","authenticated-orcid":false,"given":"Oscar Kuang-Sheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick Shu-Hang","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7475-3182","authenticated-orcid":false,"given":"Yangzi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2024.05.028_bib1","article-title":"Prevalence estimates of osteoarthritis from Global Burden of disease study 2019","author":"Long","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib3","first-page":"797","article-title":"EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritis","volume":"77","author":"Geenen","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib4","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/ard.2009.118042","article-title":"Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year","volume":"69","author":"J\u00f8rgensen","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/bjsports-2020-102179","article-title":"Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials","volume":"55","author":"Gazendam","year":"2021","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib7","article-title":"Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis","author":"V Pereira","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/boneres.2014.2","article-title":"TGF-\u03b2 signaling and the development of osteoarthritis","volume":"2","author":"Shen","year":"2014","journal-title":"Bone Res"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib9","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.joca.2019.07.004","article-title":"Bone marrow lesions in knee osteoarthritis: regional differences in tibial subchondral bone microstructure and their association with cartilage degeneration","volume":"27","author":"Muratovic","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib10","first-page":"1","article-title":"Elevated levels of active Transforming Growth Factor \u03b21 in the subchondral bone relate spatially to cartilage loss and impaired bone quality in human knee osteoarthritis","volume":"1","author":"Muratovic","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2001-15109","article-title":"TGF \u03b2 1 and TGF \u03b2 2 mRNA and protein expression in human bone samples","volume":"109","author":"Hering","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1155\/2005\/381215","article-title":"Age-dependent decrease in Serum transforming growth factor (TGF)-Beta 1 in healthy Japanese individuals; Population study of Serum TGF-beta 1 level in Japanese","volume":"21","author":"Okamoto","year":"2005","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jor.23009","article-title":"Elevated marrow inflammatory cells and osteoclasts in subchondral osteosclerosis in human knee osteoarthritis","volume":"34","author":"Geurts","year":"2016","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib14","first-page":"587","article-title":"Mechanical stress contributes to osteoarthritis development through the activation of transforming growth factor beta 1 (TGF-\u03b21), Bone Jt","volume":"7","author":"Zhang","year":"2018","journal-title":"Res."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib15","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/annrheumdis-2015-207923","article-title":"Halofuginone attenuates osteoarthritis by inhibition of TGF-\u03b2 activity and H-type vessel formation in subchondral bone","volume":"75","author":"Cui","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib16","article-title":"Artesunate, an anti-Malaria agent, attenuates experimental osteoarthritis by inhibiting bone resorption and CD31hiEmcnhi vessel formation in subchondral bone","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm.3143","article-title":"Inhibition of TGF-\u03b2 signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis","volume":"19","author":"Zhen","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/nyas.13000","article-title":"Systemic neutralization of TGF-\u03b2 attenuates osteoarthritis","volume":"1376","author":"Xie","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib19","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.ajpath.2015.07.003","article-title":"Attenuation of the progression of articular cartilage degeneration by inhibition of TGF-\u03b21 signaling in a mouse model of osteoarthritis","volume":"185","author":"Chen","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd3495","article-title":"Pirfenidone","volume":"10","author":"Richeldi","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","article-title":"Pirfenidone: molecular mechanisms and potential clinical applications in lung disease","volume":"62","author":"Ruwanpura","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","article-title":"Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study","volume":"11","author":"Solomon","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.631891","article-title":"Repurposing of pirfenidone (Anti-Pulmonary fibrosis drug) for treatment of rheumatoid arthritis","volume":"12","author":"Gan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib24","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.106.624320","article-title":"Pirfenidone prevents the development of a Vulnerable Substrate for Atrial fibrillation in a canine model of Heart Failure","volume":"114","author":"Lee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jor.23635","article-title":"Pirfenidone reduces subchondral bone loss and fibrosis after murine knee cartilage injury","volume":"36","author":"Chan","year":"2018","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib26","first-page":"1","article-title":"Pirfenidone attenuates synovial fibrosis and postpones the progression of osteoarthritis by anti - fibrotic and anti - inflammatory properties in vivo and in vitro","author":"Transl","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib27","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-018-0736-z","article-title":"Pirfenidone improves survival in IPF: results from a real-life study","volume":"18","author":"Margaritopoulos","year":"2018","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/SMMD.20220014","article-title":"Functional biomaterials for osteoarthritis treatment: from research to application","volume":"1","author":"Lei","year":"2022","journal-title":"Smart Med"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib31","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.joca.2022.04.003","article-title":"Role of synovial lymphatic function in osteoarthritis","volume":"30","author":"Cao","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib32","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.37358\/RC.17.6.5649","article-title":"Assesment of synovial fluid pH in osteoarthritis of the HIP and knee","volume":"68","author":"Roman","year":"2017","journal-title":"Rev. Chim."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1248\/bpb.b18-00091","article-title":"Two-step sustained-release plga\/hyaluronic acid gel formulation for intra-articular administration","volume":"41","author":"Noda","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib34","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.joca.2016.03.008","article-title":"Gait analysis methods for rodent models of arthritic disorders: reviews and recommendations","volume":"24","author":"Lakes","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114195","article-title":"Plastrum testudinis extract suppresses osteoclast differentiation via the NF-\u03baB signaling pathway and ameliorates senile osteoporosis","volume":"276","author":"Chen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.joca.2016.05.001","article-title":"Associations between MRI-defined structural pathology and generalized and localized knee pain \u2013 the Oulu Knee Osteoarthritis study","volume":"24","author":"Kaukinen","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.joca.2021.02.004","article-title":"A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2\/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis","volume":"29","author":"Yazici","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/annrheumdis-2019-216453","article-title":"Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial","volume":"79","author":"Eckstein","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib39","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/art.41315","article-title":"Lorecivivint, a novel intraarticular CDC-like kinase 2 and dual-specificity tyrosine phosphorylation-regulated kinase 1A inhibitor and Wnt pathway modulator for the treatment of knee osteoarthritis: a phase II randomized trial","volume":"72","author":"Yazici","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"21","key":"10.1016\/j.bioactmat.2024.05.028_bib40","article-title":"Subchondral bone remodeling: a therapeutic target for osteoarthritis","volume":"8","author":"Zhu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.joca.2021.11.009","article-title":"Osteoarthritis year in review 2021: biology, Osteoarthr","volume":"30","author":"Jiang","year":"2022","journal-title":"Cartil"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib42","article-title":"Pirfenidone for idiopathic pulmonary fibrosis and beyond, card. Fail","volume":"8","author":"Aimo","year":"2022","journal-title":"Rev"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.169.1.291","article-title":"Active and latent forms of transforming growth factor beta activity in synovial effusions","volume":"169","author":"Fava","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib44","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib45","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fi brosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib46","first-page":"2083","author":"Glaspole","year":"2022","journal-title":"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib47","first-page":"1","article-title":"Inflammation-regulated auto aggregated hydrogel microspheres via anchoring cartilage deep matrix for genes delivery","volume":"33","author":"Chen","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib48","first-page":"18","article-title":"Injectable hydrogel microspheres in cartilage repair, Biomed","volume":"1","author":"Lin","year":"2023","journal-title":"Technol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib49","first-page":"316","article-title":"Developing hierarchical microneedles for biomedical applications","volume":"4","author":"Lu","year":"2023","journal-title":"Eng. Regen."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2013-203972","article-title":"Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis","volume":"74","author":"Binks","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib51","article-title":"In situ sustained macrophage-targeted nanomicelle\u2013hydrogel microspheres for inhibiting osteoarthritis","volume":"6","author":"Li","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.bioactmat.2024.05.028_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(02)01758-2","article-title":"A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-\u03b1 at the translational level","volume":"446","author":"Nakazato","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib53","first-page":"275","article-title":"Modulation of articular chondrocyte activity by pirfenidone","volume":"113\u2013114","author":"Benton","year":"2003","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"10.1016\/j.bioactmat.2024.05.028_bib54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.joca.2021.02.007","article-title":"Comparison of joint degeneration and pain in male and female mice in DMM model of osteoarthritis","volume":"29","author":"Hwang","year":"2021","journal-title":"Osteoarthr. Cartil."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24001944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24001944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:19:55Z","timestamp":1722971995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24001944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":54,"alternative-id":["S2452199X24001944"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.05.028","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-articular sustained-release of pirfenidone as a disease-modifying treatment for early osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}